In Trial, Pill Doubles Pancreatic Cancer Survival

A pill that's been in the works since the Carter administration has changed the math on one of the deadliest cancers. In a study of 500 people with advanced pancreatic cancer whose disease had already worsened after one round of treatment, those who took the experimental drug daraxonrasib lived a...